The aim of the conference is to harness cross-disciplinary and cross-disease learning to accelerate drug discovery and reduce drug candidate attrition rates for infectious diseases affecting low and middle income countries.
Sessions
The current situation
Date: Sunday, 12 May 2019
Time: 17:00-17:40
The global situation |
Clinical development and connectivity to the preclinical situation
Date: Monday, 13 May 2019
Time: 10:20-11:00
Clinical trials for Chagas Disease. Understanding clinical PK/PD relationships. How can we do trials for Chagas disease better? |
Poster session
New start points & targets
Date: Wednesday, 15 May 2019
Time: 12:30-13:30
New leads for Chagas disease and leishmaniasis from the Lead Optimization Latin America (LOLA) Consortium |
Development of chemical probes and on-target cellular assays to enable Aminoacyl-tRNA Synthetases as targets for drug discovery against leishmaniasis |
*Presenting author
More information:
